Literature DB >> 17410020

Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure.

Cesare Gridelli, Paolo Maione, Domenico Galetta, Antonio Rossi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410020     DOI: 10.1097/JTO.0b013e31802bffb0

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation.

Authors:  Weronika Maria Szejniuk; Tine McCulloch; Oluf Dimitri Røe
Journal:  BMJ Case Rep       Date:  2014-07-23

2.  Epidermal growth factor receptor tyrosine kinase inhibitors for elderly patients with advanced non-small cell lung cancer.

Authors:  F Meriggi; A Zaniboni
Journal:  Curr Gerontol Geriatr Res       Date:  2010-06-20

Review 3.  Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure.

Authors:  Kenichi Fujita; Natsumi Matsumoto; Hiroo Ishida; Yutaro Kubota; Shinichi Iwai; Motoko Shibanuma; Yukio Kato
Journal:  Curr Drug Metab       Date:  2019       Impact factor: 3.731

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.